AbbVie Historical Balance Sheet

ABBV Stock

USD 198.55 1.36 0.69%

Trend analysis of AbbVie Inc balance sheet accounts such as Total Assets of 85.7 B, Other Current Liabilities of 30.4 B or Total Current Liabilities of 20.2 B provides information on AbbVie's total assets, liabilities, and equity, which is the actual value of AbbVie Inc to its prevalent stockholders. By breaking down trends over time using AbbVie balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining AbbVie Inc latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether AbbVie Inc is a good buy for the upcoming year.

AbbVie Inventory

2.31 Billion

Build AI portfolio with AbbVie Stock

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AbbVie Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.

About AbbVie Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of AbbVie Inc at a specified time, usually calculated after every quarter, six months, or one year. AbbVie Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of AbbVie and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which AbbVie currently owns. An asset can also be divided into two categories, current and non-current.

AbbVie Balance Sheet Chart

At this time, AbbVie's Other Current Liabilities is fairly stable compared to the past year. Other Liabilities is likely to climb to about 38.3 B in 2025, whereas Total Assets are likely to drop slightly above 85.7 B in 2025.

Common Stock Shares Outstanding Total Assets Other Current Liab Total Current Liabilities

Add Fundamental

Common Stock Shares Outstanding

The total number of shares of a company's common stock that are currently owned by all its shareholders.

Total Assets

Total assets refers to the total amount of AbbVie assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in AbbVie Inc books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on AbbVie balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of AbbVie Inc are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Most accounts from AbbVie's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into AbbVie Inc current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AbbVie Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.

	2022	2023	2024	2025 (projected)
Other Current Liabilities	22.3B	27.0B	29B	30.5B
Total Assets	138.8B	134.7B	135.2B	85.7B

Other Current Liab Total Assets

AbbVie balance sheet Correlations

	Common Stock Shares Outstanding	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Property Plant And Equipment Net	Net Debt	Accounts Payable	Cash	Non Current Assets Total	Other Assets	Cash And Short Term Investments	Net Receivables	Good Will	Short Term Investments	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Intangible Assets	Property Plant Equipment	Short Long Term Debt Total
Common Stock Shares Outstanding		0.62	0.82	0.74	0.38	0.71	0.73	0.59	0.68	-0.28	0.67	0.79	-0.3	0.76	0.71	-0.36	0.5	0.77	0.67	0.65	0.57	0.86	0.13	0.63	0.76	0.45
Total Assets	0.62		0.81	0.94	0.29	0.91	0.97	0.96	0.91	0.26	0.98	0.87	0.24	0.93	0.99	-0.42	0.98	0.94	0.68	0.4	0.99	0.77	0.65	0.97	0.96	0.95
Other Current Liab	0.82	0.81		0.87	0.18	0.95	0.86	0.75	0.84	0.12	0.81	0.96	0.1	0.88	0.85	-0.42	0.76	0.88	0.64	0.41	0.81	0.97	0.51	0.76	0.84	0.73
Total Current Liabilities	0.74	0.94	0.87		0.24	0.89	0.96	0.89	0.96	0.15	0.93	0.87	0.13	0.96	0.96	-0.44	0.89	0.97	0.72	0.42	0.94	0.85	0.58	0.9	0.97	0.86
Total Stockholder Equity	0.38	0.29	0.18	0.24		0.15	0.4	0.23	0.22	-0.5	0.39	0.29	-0.53	0.37	0.32	-0.22	0.1	0.3	0.52	0.92	0.14	0.32	-0.25	0.43	0.38	0.05
Other Liab	0.71	0.91	0.95	0.89	0.15		0.89	0.88	0.86	0.22	0.9	0.94	0.2	0.88	0.92	-0.42	0.9	0.89	0.68	0.33	0.91	0.89	0.6	0.87	0.87	0.88
Property Plant And Equipment Net	0.73	0.97	0.86	0.96	0.4	0.89		0.93	0.91	0.1	0.98	0.91	0.07	0.97	0.98	-0.46	0.9	0.97	0.71	0.55	0.94	0.84	0.53	0.96	0.99	0.87
Net Debt	0.59	0.96	0.75	0.89	0.23	0.88	0.93		0.84	0.14	0.97	0.82	0.13	0.87	0.96	-0.31	0.96	0.88	0.6	0.35	0.96	0.69	0.53	0.98	0.93	0.95
Accounts Payable	0.68	0.91	0.84	0.96	0.22	0.86	0.91	0.84		0.19	0.9	0.83	0.16	0.94	0.93	-0.46	0.86	0.95	0.67	0.37	0.91	0.83	0.59	0.86	0.9	0.82
Cash	-0.28	0.26	0.12	0.15	-0.5	0.22	0.1	0.14	0.19		0.08	0.11	1.0	0.11	0.13	-0.26	0.41	0.14	-0.09	-0.52	0.35	0.04	0.88	0.06	0.08	0.45
Non Current Assets Total	0.67	0.98	0.81	0.93	0.39	0.9	0.98	0.97	0.9	0.08		0.87	0.06	0.93	0.99	-0.39	0.93	0.94	0.71	0.51	0.95	0.78	0.51	0.99	0.97	0.91
Other Assets	0.79	0.87	0.96	0.87	0.29	0.94	0.91	0.82	0.83	0.11	0.87		0.08	0.89	0.88	-0.47	0.81	0.9	0.64	0.51	0.84	0.92	0.5	0.84	0.89	0.79
Cash And Short Term Investments	-0.3	0.24	0.1	0.13	-0.53	0.2	0.07	0.13	0.16	1.0	0.06	0.08		0.08	0.11	-0.2	0.39	0.11	-0.12	-0.55	0.33	0.01	0.87	0.04	0.05	0.43
Net Receivables	0.76	0.93	0.88	0.96	0.37	0.88	0.97	0.87	0.94	0.11	0.93	0.89	0.08		0.96	-0.4	0.86	0.98	0.69	0.51	0.91	0.88	0.55	0.9	0.96	0.82
Good Will	0.71	0.99	0.85	0.96	0.32	0.92	0.98	0.96	0.93	0.13	0.99	0.88	0.11	0.96		-0.41	0.94	0.97	0.71	0.46	0.97	0.81	0.56	0.97	0.98	0.91
Short Term Investments	-0.36	-0.42	-0.42	-0.44	-0.22	-0.42	-0.46	-0.31	-0.46	-0.26	-0.39	-0.47	-0.2	-0.4	-0.41		-0.37	-0.44	-0.35	-0.32	-0.4	-0.43	-0.37	-0.38	-0.45	-0.37
Non Current Liabilities Total	0.5	0.98	0.76	0.89	0.1	0.9	0.9	0.96	0.86	0.41	0.93	0.81	0.39	0.86	0.94	-0.37		0.89	0.57	0.21	0.99	0.68	0.74	0.92	0.89	0.99
Inventory	0.77	0.94	0.88	0.97	0.3	0.89	0.97	0.88	0.95	0.14	0.94	0.9	0.11	0.98	0.97	-0.44	0.89		0.68	0.48	0.93	0.86	0.57	0.9	0.97	0.84
Other Current Assets	0.67	0.68	0.64	0.72	0.52	0.68	0.71	0.6	0.67	-0.09	0.71	0.64	-0.12	0.69	0.71	-0.35	0.57	0.68		0.6	0.62	0.7	0.3	0.68	0.71	0.52
Other Stockholder Equity	0.65	0.4	0.41	0.42	0.92	0.33	0.55	0.35	0.37	-0.52	0.51	0.51	-0.55	0.51	0.46	-0.32	0.21	0.48	0.6		0.27	0.52	-0.2	0.52	0.55	0.16
Total Liab	0.57	0.99	0.81	0.94	0.14	0.91	0.94	0.96	0.91	0.35	0.95	0.84	0.33	0.91	0.97	-0.4	0.99	0.93	0.62	0.27		0.74	0.72	0.94	0.93	0.98
Property Plant And Equipment Gross	0.86	0.77	0.97	0.85	0.32	0.89	0.84	0.69	0.83	0.04	0.78	0.92	0.01	0.88	0.81	-0.43	0.68	0.86	0.7	0.52	0.74		0.44	0.74	0.82	0.65
Total Current Assets	0.13	0.65	0.51	0.58	-0.25	0.6	0.53	0.53	0.59	0.88	0.51	0.5	0.87	0.55	0.56	-0.37	0.74	0.57	0.3	-0.2	0.72	0.44		0.48	0.51	0.76
Intangible Assets	0.63	0.97	0.76	0.9	0.43	0.87	0.96	0.98	0.86	0.06	0.99	0.84	0.04	0.9	0.97	-0.38	0.92	0.9	0.68	0.52	0.94	0.74	0.48		0.95	0.9
Property Plant Equipment	0.76	0.96	0.84	0.97	0.38	0.87	0.99	0.93	0.9	0.08	0.97	0.89	0.05	0.96	0.98	-0.45	0.89	0.97	0.71	0.55	0.93	0.82	0.51	0.95		0.86
Short Long Term Debt Total	0.45	0.95	0.73	0.86	0.05	0.88	0.87	0.95	0.82	0.45	0.91	0.79	0.43	0.82	0.91	-0.37	0.99	0.84	0.52	0.16	0.98	0.65	0.76	0.9	0.86

Click cells to compare fundamentals

AbbVie Account Relationship Matchups

AbbVie balance sheet Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Common Stock Shares Outstanding	1.7B	1.8B	1.8B	1.8B	2.0B	1.8B
Total Assets	150.6B	146.5B	138.8B	134.7B	135.2B	85.7B
Other Current Liab	17.7B	19.6B	22.3B	27.0B	29B	30.5B
Total Current Liabilities	28.7B	35.2B	29.5B	37.8B	38.7B	20.2B
Total Stockholder Equity	13.1B	15.4B	17.3B	10.4B	3.3B	3.2B
Other Liab	18.5B	30.4B	31.0B	31.7B	36.5B	38.3B
Property Plant And Equipment Net	5.2B	5.1B	4.9B	5.0B	5.1B	3.7B
Net Debt	78.6B	67.8B	55.0B	47.3B	62.3B	34.8B
Accounts Payable	2.3B	2.9B	2.9B	3.7B	2.9B	1.9B
Cash	8.4B	9.7B	9.2B	12.8B	5.5B	10.2B
Non Current Assets Total	126.4B	118.6B	110.3B	101.7B	109.6B	61.9B
Other Assets	1.9B	5.1B	4.1B	4.8B	5.6B	5.8B
Cash And Short Term Investments	8.5B	9.8B	9.2B	12.8B	5.6B	10.7B
Net Receivables	8.8B	10.0B	11.3B	11.2B	10.9B	7.2B
Good Will	33.1B	32.4B	32.2B	32.3B	35.0B	19.9B
Short Term Investments	30M	84M	28M	2M	31M	29.5M
Liabilities And Stockholders Equity	150.6B	146.5B	138.8B	134.7B	135.2B	85.7B
Non Current Liabilities Total	108.8B	95.9B	92.0B	86.5B	93.0B	58.7B
Inventory	3.3B	3.1B	3.6B	4.1B	4.2B	2.3B
Other Stockholder Equity	15.1B	15.2B	14.7B	13.6B	13.1B	7.6B
Total Liab	137.5B	131.1B	121.5B	124.3B	131.8B	78.8B
Property Plant And Equipment Gross	5.2B	10.7B	11.0B	11.6B	12.3B	12.9B
Total Current Assets	24.2B	27.9B	28.5B	33.0B	25.6B	23.8B
Accumulated Other Comprehensive Income	(3.1B)	(2.9B)	(2.2B)	(2.3B)	(1.9B)	(2.0B)
Intangible Assets	82.9B	76.0B	67.4B	55.6B	60.1B	34.5B
Property Plant Equipment	3.0B	5.2B	5.1B	4.9B	5.7B	3.4B
Short Long Term Debt Total	87.1B	77.6B	64.2B	60.1B	67.8B	48.4B
Non Currrent Assets Other	4.9B	4.9B	5.6B	8.5B	9.1B	9.6B
Long Term Debt	77.6B	64.2B	59.1B	52.2B	60.3B	43.0B
Short Term Debt	8.7B	12.7B	4.3B	7.2B	6.8B	5.0B
Net Tangible Assets	(42.4B)	(102.9B)	(96.2B)	(82.3B)	(74.1B)	(77.8B)
Noncontrolling Interest In Consolidated Entity	21M	28M	33M	37M	42.6M	44.7M
Retained Earnings	1.1B	3.1B	4.8B	(1B)	(7.9B)	(7.5B)
Retained Earnings Total Equity	4.7B	1.1B	3.1B	4.8B	5.5B	3.4B
Long Term Debt Total	63.0B	77.6B	64.2B	59.1B	68.0B	50.1B
Capital Surpluse	15.2B	17.4B	18.3B	19.2B	22.1B	15.8B
Additional Paid In Capital	17.4B	18.3B	19.2B	20.2B	23.2B	15.0B

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for AbbVie Stock Analysis

When running AbbVie's price analysis, check to measure AbbVie's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AbbVie is operating at the current time. Most of AbbVie's value examination focuses on studying past and present price action to predict the probability of AbbVie's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AbbVie's price. Additionally, you may evaluate how the addition of AbbVie to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2025 Macroaxis LLC

AbbVie Historical Balance Sheet

AbbVie Inventory

2.31 Billion

About AbbVie Balance Sheet Analysis

AbbVie Balance Sheet Chart

Common Stock Shares Outstanding

Total Assets

Total Current Liabilities

AbbVie balance sheet Correlations

AbbVie Account Relationship Matchups

High Positive Relationship

High Negative Relationship

AbbVie balance sheet Accounts

Thematic Opportunities

Explore Investment Opportunities

Additional Tools for AbbVie Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Cash
Good Will	+ 0.99	Total Assets
Total Liab	+ 0.99	Total Assets
Property Plant Equipment	+ 0.99	Property Plant And Equipment Net
Good Will	+ 0.99	Non Current Assets Total
Intangible Assets	+ 0.99	Non Current Assets Total

Other Stockholder Equity	- 0.55	Cash And Short Term Investments
Cash And Short Term Investments	- 0.53	Total Stockholder Equity
Other Stockholder Equity	- 0.52	Cash
Cash	- 0.5	Total Stockholder Equity
Short Term Investments	- 0.47	Other Assets
Short Term Investments	- 0.46	Accounts Payable